<html>
<head>PUBMED IDs for CT100</head>
<body bgcolor='#C5F0F2'><h1>CT100</h1><a href='https://pubmed.ncbi.nlm.nih.gov/9681463/'>Acetylcholinesterase is increased in the brains of transgenic mice expressing the C-terminal fragment (CT100) of the beta-amyloid protein precursor of Alzheimer's disease.</a> July 29  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/15601849/'>Increased tau phosphorylation on mitogen-activated protein kinase consensus sites and cognitive decline in transgenic models for Alzheimer's disease and FTDP-17: evidence for distinct molecular processes underlying tau abnormalities.</a> December 17  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15821343/'>Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease.</a> April 12  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/19705800/'>Expression and serum immunoreactivity of developmentally restricted differentiation antigens in epithelial ovarian cancer.</a> October 15  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20098622/'>S100a9 knockdown decreases the memory impairment and the neuropathology in Tg2576 mice, AD animal model.</a> May 21  2010<br></body></html>
